Product News

Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit’s mission is “Innovating for Health”.
Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare.

Quit smoking with Acetium® – nicotine free

Acetium lozenge works by slowly releasing L-cysteine (a natural amino acid) into saliva. Acetium lozenge is a safe and effective way of quit smoking.

Science behind the products

Biohit HealthCare’s unique GastroPanel® examinations diagnose diseases of the stomach and the risks associated with these diseases. Our quick tests provide diagnosis of lactose intolerance and Helicobacter pylori infection, as well as fecal occult blood, a well-known marker for colorectal cancer.

Investing Opportunities

Biohit’s Series B shares (BIOBV) are listed in Nasdaq OMX Helsinki Oy’s Small Cap group and in the Healthcare sub-sector.

Quality analysis

Biohit Laboratory Services Oy promotes the evaluation and adoption of Biohit’s diagnostic tests and analysing systems. Biohit Laboratory Services engages in the research and development of diagnostic tests and the analysis of different types of patient data in cooperation with scientific communities in Finland and abroad

Become our partner or distributor

Are you looking for growth opportunities?